Novel Treatment for Farsightedness
(EVA-II Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
To determine if wearing a novel treatment during a 15-month period will enhance emmetropization in 4-month-old infants who have demonstrated poor ocular accommodation (eye focusing).
Are You a Good Fit for This Trial?
This trial is for 4-month-old infants who have trouble focusing their eyes (poor accommodation) and are farsighted. Other health or eye conditions may exclude participation.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Experimental treatment arm
Trial Overview
Researchers are testing if a new treatment, worn by the infant over 15 months, can help improve normal eye development and focusing ability compared to usual care.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants will receive experimental treatment.
No treatment is administered in this arm.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.